Clinical trial NCT00459940 - References

Growth Hormone Deficiency — The Effects of TZD on Fat Metabolism and Insulin Sensitivity in GH-Replaced GHD Patients

Citation(s)

•   Alford FP, Hew FL, Christopher MC, Rantzau C
  Insulin sensitivity in growth hormone (GH)-deficient adults and effect of GH replacement therapy. J Endocrinol Invest. 1999;22(5 Suppl):28-32.
•   Boden G, Cheung P, Mozzoli M, Fried SK
  Effect of thiazolidinediones on glucose and fatty acid metabolism in patients with type 2 diabetes. Metabolism. 2003 Jun;52(6):753-9.
•   Nielsen S, Møller N, Christiansen JS, Jørgensen JO
  Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure. Diabetes. 2001 Oct;50(10):2301-8.
•   Nielsen S, Møller N, Pedersen SB, Christiansen JS, Jørgensen JO
  The effect of long-term pharmacological antilipolysis on substrate metabolism in growth hormone (GH)-substituted GH-deficient adults. J Clin Endocrinol Metab. 2002 Jul;87(7):3274-8.
•   Nørrelund H, Djurhuus C, Jørgensen JO, Nielsen S, Nair KS, Schmitz O, Christiansen JS, Møller N
  Effects of GH on urea, glucose and lipid metabolism, and insulin sensitivity during fasting in GH-deficient patients. Am J Physiol Endocrinol Metab. 2003 Oct;285(4):E737-43. Epub 2003 Jun 10.
•   Racette SB, Davis AO, McGill JB, Klein S
  Thiazolidinediones enhance insulin-mediated suppression of fatty acid flux in type 2 diabetes mellitus. Metabolism. 2002 Feb;51(2):169-74.
•   Spiegelman BM
  PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. Diabetes. 1998 Apr;47(4):507-14. Review.

"Can Growth Hormone's Lipolytic and Insulin-Antagonistic Effects be Modified by Peroxisome Proliferator-Activated Gamma Agonists?"

Details for clinical trial NCT00459940